SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    T. W. J. Huizinga, P. G. Conaghan, E. Martin-Mola, G. Schett, H. Amital, R. M. Xavier, O. Troum, M. Aassi, C. Bernasconi, M. Dougados, Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study, Annals of the Rheumatic Diseases, 2015, 74, 1, 35

    CrossRef

  2. 2
    Marina Backhaus, Jörg Kaufmann, Constanze Richter, Siegfried Wassenberg, Anne-Eve Roske, Peter Hellmann, Markus Gaubitz, Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice, Clinical Rheumatology, 2015, 34, 4, 673

    CrossRef

  3. 3
    Vivian P. Bykerk, Andrew J. K. Östör, José Alvaro-Gracia, Karel Pavelka, José Andrés Román Ivorra, Winfried Graninger, William Bensen, Michael T. Nurmohamed, Andreas Krause, Corrado Bernasconi, Maher Aassi, Jean Sibilia, Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice, Clinical Rheumatology, 2015, 34, 3, 563

    CrossRef

  4. 4
    Alejandro Balsa, Juan Víctor Tovar Beltrán, Rafael Cáliz Cáliz, Isabel Mateo Bernardo, Rosario García-Vicuña, Manuel Rodríguez-Gómez, Miguel Angel Belmonte Serrano, Carlos Marras, Eduardo Loza Cortina, Eva Pérez-Pampin, Vicente Vila, Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE study, Rheumatology International, 2015,

    CrossRef

  5. 5
    Deepali Sen, María González-Mayda, Richard D. Brasington, Cardiovascular Disease in Rheumatoid Arthritis, Rheumatic Disease Clinics of North America, 2014, 40, 1, 27

    CrossRef

  6. 6
    M. Dougados, K. Kissel, P. G. Conaghan, E. M. Mola, G. Schett, R. Gerli, M. S. Hansen, H. Amital, R. M. Xavier, O. Troum, C. Bernasconi, T. W. J. Huizinga, Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study, Annals of the Rheumatic Diseases, 2014, 73, 5, 803

    CrossRef

  7. 7
    Carolyn M Dancevic, Daniel R McCulloch, Current and emerging therapeutic strategies for preventing inflammation and aggrecanase-mediated cartilage destruction in arthritis, Arthritis Research & Therapy, 2014, 16, 5, 429

    CrossRef

  8. 8
    Sohita Dhillon, Intravenous Tocilizumab: A Review of Its Use in Adults with Rheumatoid Arthritis, BioDrugs, 2014, 28, 1, 75

    CrossRef

  9. 9
    Bonnie L. Bermas, Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy, Current Opinion in Rheumatology, 2014, 26, 3, 334

    CrossRef

  10. 10
    Maria Gonzalez-Mayda, Deepali Sen, Richard Brasington, Rheumatoid arthritis and cardiac disease, International Journal of Clinical Rheumatology, 2014, 9, 5, 457

    CrossRef

  11. 11
    P. Emery, A. Sebba, T. W. J. Huizinga, Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis, Annals of the Rheumatic Diseases, 2013, 72, 12, 1897

    CrossRef